3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 30.90
-1.40 (-4.33%)
Aug 6, 2025, 11:59 AM HKT
Splunk Market Cap
3SBio has a market cap or net worth of 77.26 billion as of August 5, 2025. Its market cap has increased by 384.91% in one year.
Market Cap
77.26B
Enterprise Value
77.08B
Revenue
9.69B
Ranking
n/a
PE Ratio
35.71
Stock Price
$30.90
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 77.26B, an increase of 240.82%. That is a compound annual growth rate of 12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 77.26B | 439.53% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | 17.98B | -29.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| Sino Biopharmaceutical | 130.92B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |